Agreed. This is VERY positive news. If you are u
Post# of 155264

1) We are requesting EUA in several countries including our own.
2) If we have to do a phase 3, it will be small and will enroll quickly.
3) CD12 Interim results are 45-60 days out and I believe is a show in for EUA approval.
4) No other drug has shown any efficacy in the M2M group.
5) M2M is likely the most difficult group to show efficacy in. S/C will be a slam dunk.
6) CYDY is getting ready to launch more trials, and is bringing in experts in various fields to assist.
7) Uplisting is progressing. Audited financials complete this week.

I couldnt be happier with how thing are progressing.

